Epidemic dynamics of two coexisting hepatitis C virus subtypes

Journal of General Virology

Volumn 88, Issue 1, 2007, Pages 123-133

  Jiménez Hernández, Nuria ^a   Torres Puente, Manuela ^a   Bracho, Maria Alma ^a   García Robles, Inmaculada ^a   Ortega, Enrique ^b   del Olmo, Juan ^c   Carnicer, Fernando ^d   Gonzáles Candelas, Fernando ^a   Moya, Andrés ^a  

^a UNIVERSITY OF VALENCIA   (Spain)

^b HOSPITAL GENERAL UNIVERSITARIO DE VALENCIA   (Spain)

^c HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

^d HOSPITAL GENERAL UNIVERSITARIO DE ALICANTE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

INTERFERON;

AGE; ANALYSIS OF VARIANCE; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; EPIDEMIC; EUROPE; GENDER; GENETIC POLYMORPHISM; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INCIDENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; RISK ASSESSMENT; SEQUENCE ANALYSIS; UNINDEXED SEQUENCE; VIRUS GENOME; VIRUS TRANSMISSION; VIRUS TYPING;

ANALYSIS OF VARIANCE; HEPACIVIRUS; HEPATITIS C, CHRONIC; HUMANS; MOLECULAR SEQUENCE DATA; VARIATION (GENETICS);

HEPATITIS C VIRUS;

EID: 33846155234     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.82277-0     Document Type: Article

References (56)

1. Abe, K., Inchauspe, G. & Fujisawa, K. (1992). Genomic characterization and mutation rate of hepatitis C virus isolated from a patient who contracted hepatitis during an epidemic of non-A, non-B hepatitis in Japan. J Gen Virol 73, 2725-2729.
2. Akaike, H. (1974). A new look at the statistical model identification. IEEE Trans Autom Control 19, 716-723.
3. Bolumar, F., Hernández-Aguado, I., Ferrer, L., Ruiz, I., Avino, M. J. & Rebagliato, M. (1996). Prevalence of antibiotics to hepatitis C in a population of intravenous drug users in Valencia, Spain, 1990-1992. Int J Epidemiol 25, 204-209.
4. Bracho, M. A., Garcia-Robles, I., Jiménez, N., Torres-Puente, M., Moya, A. & González-Candelas, F. (2004). Effect of oligonucleotide primers in determining viral variability within hosts. Virol J 1, 13.
5. Choo, Q. L., Kuo, G., Weiner, A. J., Overby, L. R., Bradley, D. W. & Houghton, M. (1989). Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 244, 359-362.
6. Cochrane, A. & Simmonds, P. (2002). Molecular epidemiology of hepatitis C virus. In The Molecular Epidemiology of Human Viruses, pp. 197-216. Edited by T. Leiner. Dordrecht: Kluwer Acadademic.
7. Dominguez, A., Bruguera, M., Vidal, J., Plans, P. & Salleras, L. (2001). Community-based seroepidemiological survey of HCV infection in Catalonia, Spain. J Med Virol 65, 688-693.
8. Donahue, J. G., Muñoz, A., Ness, P. M., Brown, D. E., Jr, Yawn, D. H., McAllister, H. A., Jr, Reitz, B. A. & Nelson, K. E. (1992). The declining risk of post-transfusion hepatitis C virus infection. N Engl J Med 327, 369-373.
9. Excoffier, L., Smouse, P. E. & Quattro, J. M. (1992). Analysis of molecular variance inferred from metric distances among DNA haplotypes: application to human mitochondrial DNA restriction data. Genetics 131, 479-491.
10. Forns, X., Maluenda, M. D., Lopez-Labrador, F. X., Ampurdanes, S., Olmedo, E., Costa, J., Simmonds, P., Sanchez-Tapias, J. M., Jimenez De Anta, M. T. & Rodes, J. (1996). Comparative study of three methods for genotyping hepatitis C virus strains in samples from Spanish patients. J Clin Microbiol 34, 2516-2521.
11. Griffiths, R. C. & Tavaré, S. (1994). Sampling theory for neutral alleles in a varying environment. Philos Trans R Soc Lond B Biol Sci 344, 403-410.
12. Holmes, E. C. (2003). Molecular clocks and the puzzle of RNA virus origins. J Virol 77, 3893-3897.
13. Holmes, E. C., Nee, S., Rambaut, A., Garnett, G. P. & Harvey, P. H. (1995). Revealing the history of infectious disease epidemics through phylogenetic trees. Philos Trans R Soc Lond B Biol Sci 349, 33-40.
14. Hudson, R. R. (1991). Gene genealogies and the coalescent process. Oxford Surv Evol Biol 7, 1-44.
15. Kalinina, O., Norder, H., Vetrov, T., Zhdanov, K., Barzunova, M., Plotnikova, V., Mukomolov, S. & Magnius, L. O. (2001). Shift in predominating subtype of HCV from 1b to 3a in St Petersburg mediated by increase in injecting drug use. J Med Virol 65, 517-524.
16. Kingman, J. F. C. (1982). On the genealogy of large populations. J Appl Probab 19, 27-43.
17. Kumar, S., Tamura, K. & Nei, M. (2004). MEGA3: integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment. Brief Bioinform 5, 150-163.
18. López-Labrador, F. X., Ampurdanés, S., Forns, X., Castells, A., Saiz, J. C., Costa, J., Bruix, J., Sanchez Tapias, J. M., Jimenez de Anta, M. T. & Rodes, J. (1997). Hepatitis C virus (HCV) genotypes in Spanish patients with HCV infection: relationship between HCV genotype 1b, cirrhosis and hepatocellular carcinoma. J Hepatol 27, 959-965.
19. Memon, M. I. & Memon, M. A. (2002). Hepatitis C: an epidemiological review. J Viral Hepat 9, 84-100.
20. Mondelli, M. U. & Silini, E. (1999). Clinical significance of hepatitis C virus genotypes. J Hepatol 31 (Suppl. 1), 65-70.
21. Moreno Planas, J. M., Fernández Ruiz, M., Portero Azorín, F., Boullosa Grana, E., Rubio Gonzalez, E., Martin Garcia, S., Martinez Arrieta, F., Jimenez Garrido, M., Sanchez Turrion, V. & Cuervas-Mons Martinez, V. (2005). Prevalence of hepatitis C virus genotypes in a Spanish liver transplant unit. Transplant Proc 37, 1486-1487.
22. Mortimer, P. P. (1995). Arsphenamine jaundice and the recognition of instrument-borne virus infection. Genitourin Med 71, 109-119.
23. Moya, A., Holmes, E. C. & González-Candelas, F. (2004). The population genetics and evolutionary epidemiology of RNA viruses. Nat Rev Microbiol 2, 279-288.
24. Nakano, T., Lu, L., Liu, P. & Pybus, O. G. (2004). Viral gene sequences reveal the variable history of hepatitis C virus infection among countries. J Infect Dis 190, 1098-1108.
25. Pawlotsky, J. M., Tsakiris, L., Roudot-Thoraval, F., Pellet, C., Stuyver, L., Duval, J. & Dhumeaux, D. (1995). Relationship between hepatitis C virus genotypes and sources of infection in patients with chronic hepatitis C. J Infect Dis 171, 1607-1610.
26. Payan, C., Roudot-Thoraval, F., Marcellin, P., Bled, N., Duverlie, G., Fouchard-Hubert, I., Trimoulet, P., Couzigou, P., Cointe, D. & other authors (2005). Changing of hepatitis C virus genotype patterns in France at the beginning of the third millenium: the GEMHEP GenoCII Study. J Viral Hepat 12, 405-413.
27. Pol, S., Thiers, V., Nousbaum, J. B., Legendre, C., Berthelot, P., Kreis, H. & Brechot, C. (1995). The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients. Gastroenterology 108, 581-583.
28. Posada, D. & Crandall, K. A. (1998). MODELTEST: testing the model of DNA substitution. Bioinformatics 14, 817-818.
29. Pybus, O. G. & Rambaut, A. (2002). GENIE: estimating demographic history from molecular phylogenies. Bioinformatics 18, 1404-1405.
30. Pybus, O. G., Rambaut, A. & Harvey, P. H. (2000). An integrated framework for the inference of viral population history from reconstructed genealogies. Genetics 155, 1429-1437.
31. Pybus, O. G., Charleston, M. A., Gupta, S., Rambaut, A., Holmes, E. C. & Harvey, P. H. (2001). The epidemic behavior of the hepatitis C virus. Science 292, 2323-2325.
32. Pybus, O. G., Drummond, A. J., Nakano, T., Robertson, B. H. & Rambaut, A. (2003). The epidemiology and iatrogenic transmission of hepatitis C virus in Egypt: a Bayesian coalescent approach. Mol Biol Evol 20, 381-387.
33. Pybus, O. G., Cochrane, A., Holmes, E. C. & Simmonds, P. (2005). The hepatitis C virus epidemic among injecting drug users. Infect Genet Evol 5, 131-139.
34. Rambaut, A. (2000). Estimating the rate of molecular evolution: incorporating non-contemporaneous sequences into maximum likelihood phylogenies. Bioinformatics 16, 395-399.
35. Ramos-Sánchez, M. C., Torio-Cabezón, R., Mazón-Ramos, M. A., Martin-Gil, F. J. & del Alamo, M. (2003). Hepatitis C virus genotype 4 in a North-west Spain district. J Clin Virol 28, 223-224.
36. Rozas, J., Sánchez-del Barrio, J. C., Messeguer, X. & Rozas, R. (2003). DnaSP, DNA polymorphism analyses by the coalescent and other methods. Bioinformatics 19, 2496-2497.
37. Santana Rodríguez, O. E., Male Gil, M. L., Hernández Santana, J. F., Liminana Canal, J. M. & Martín Sánchez, A. M. (1998). Prevalence of serologic markers of HBV, HDV, HCV and HIV in non-injection drug users compared to injection drug users in Gran Canaria, Spain. Eur J Epidemiol 14, 555-561.
38. Schneider, S., Roessli, D. & Excoffier, L. (2000). ARLEQUIN version 2000: a software for population genetic data analysis. Genetics and Biometry Laboratory. University of Geneva, Switzerland.
39. Simmonds, P. (2004). Genetic diversity and evolution of hepatitis C virus - 15 years on. J Gen Virol 85, 3173-3188.
40. Simmonds, P., Holmes, E. C., Cha, T. A., Chan, S. W., McOmish, F., Irvine, B., Beall, E., Yap, P. L., Kolberg, J. & Urdea, M. S. (1993). Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74, 2391-2399.
41. Simmonds, P., Mellor, J., Craxi, A., Sanchez-Tapias, J. M., Alberti, A., Prieto, J., Colombo, M., Rumi, M. G., Lo Iacano, O. & other authors (1996). Epidemiological, clinical and therapeutic associations of hepatitis C types in western European patients. J Hepatol 24, 517-524.
42. Slatkin, M. (1991). Inbreeding coefficients and coalescence times. Genet Res 58, 167-175.
43. Smith, D. B., Pathirana, S., Davidson, F., Lawlor, E., Power, J., Yap, P. L. & Simmonds, P. (1997). The origin of hepatitis C virus genotypes. J Gen Virol 78, 321-328.
44. Staden, R., Beal, K. F. & Bonfield, J. K. (2000). The Staden package, 1998. Methods Mol Biol 132, 115-130.
45. Strimmer, K. & Pybus, O. G. (2001). Exploring the demographic history of DNA sequences using the generalized skyline plot. Mol Biol Evol 18, 2298-2305.
46. Swofford, D. L. (2001). PAUP*: phylogenetic inference using parsimony (*and other methods), version 4. Sunderland, MA: Sinauer Associates.
47. Tanaka, Y., Hanada, K., Mizokami, M., Yeo, A. E. T., Shih, J. W.-K., Gojobori, T. & Alter, H. J. (2002). A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci U S A 99, 15584-15589.
48. Tanaka, Y., Agha, S., Saudy, N., Kurbanov, F., Orito, E., Kato, T., Abo-Zeid, M., Khalaf, M., Miyakawa, Y. & Mizokami, M. (2004). Exponential spread of hepatitis C virus genotype 4a in Egypt. J Mol Evol 58, 191-195.
49. Thompson, J. D., Gibson, T. J., Plewniak, F., Jeanmougin, F. & Higgins, D. G. (1997). The CLUSTAL_X windows interface: flexible strategies for multiple sequence alignment aided by quality analysis tools. Nucleic Acids Res 25, 4876-4882.
50. Thomson, B. J. & Finch, R. G. (2005). Hepatitis C virus infection. Clin Microbiol Infect 11, 86-94.
51. Wasley, A. & Alter, M. J. (2000). Epidemiology of hepatitis C: geographic differences and temporal trends. Semin Liver Dis 20, 1-16.
52. Webster, G., Barnes, E., Brown, D. & Dusheiko, G. (2000). HCV genoty - role in pathogenesis of disease and response to therapy. Best Pract Res Clin Gastroenterol 14, 229-240.
53. Wright, S. (1951). The genetical structure of populations. Ann Eugen 15, 323-354.
54. Wright, S. (1965). The interpretation of population structure by F-statistics with special regard to systems of mating. Evolution Int J Org Evolution 19, 395-420.
55. Yu, M. L., Chuang, W. L., Chen, S. C., Dai, C. Y., Hou, C., Wang, J. H., Lu, S. N., Huang, J. F., Lin, Z. Y. & other authors (2001). Changing prevalence of hepatitis C virus genotypes: molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan. J Med Virol 65, 58-65.
56. Zein, N. N. (2000). Clinical significance of hepatitis C virus genotypes. Clin Microbiol Rev 13, 223-235.